Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin

Acta Pharmaceutica

Volumn 56, Issue 2, 2006, Pages 219-229

  Mehdizadeh, Amir ^a,b   Ghahremani, Mohammad Hossain ^a   Rouini, Mohammad Reza ^a   Toliyat, Tayebeh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Hakim Pharmaceutical Company   (Iran)

Author keywords

Fentanyl; Permeation enhancer; Pressure sensitive adhesive; Rat skin; Transdermal patches

Indexed keywords

ADHESIVE AGENT; FENTANYL; HEXADECANOL; MACROGOL; OLEIC ACID; PROPYLENE GLYCOL;

ADHESION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; SKIN PERMEABILITY; STEADY STATE; TRANSDERMAL PATCH; VISCOSITY;

EID: 33645553040     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. R. H. Guy, Current status and future prospects of transdermal drug delivery, Pharm. Res. 13 (1996) 1765-1769.
2. M. A. Ashburn, The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat, J. Pain 4 (2003) 17-22.
3. B. W. Barry, Novel mechanism and devices to enable successful transdermal delivery, Eur. J. Pharm. Sci. 14 (2001) 101-114.
4. A. M. Hillery, A. W. Lloyd and J. Swarbrick, Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists, Taylor & Francis, New York 2001, pp. 207-235.
5. R. Panchagnula, Transdermal delivery of drugs, Ind. J. Pharm. 29 (1997) 140-156.
6. V. Carelli, G. Di Colo, E. Nannipieri and M. F. Serafini, Enhancement effects in the permeation of Alprazolam through hairless mouse skin, Int. J. Pharm. 88 (1992) 89-97.
7. R. Baker, Controlled Release of Biologically Active Agents, John Wiley, New York 1987, pp. 192-205.
8. E. S. Park, S. J. Chang, Y. S. Rhee and S. C. Chi, Effects of adhesives and permeation enhancers on the skin permeation of captopril, Drug Dev. Ind. Pharm. 27 (2001) 975-980.
9. J. H. Kim, Y. J. Cho and H. K. Choi, Effects of vehicles and pressure sensitive adhesives on the permeation of tacrine across hairless mouse skin, Int. J. Pharm. 196 (2000) 105-113.
10. D. A. Dimas, P. P. Dallas, D. M. Rekkas and N. H. Choulis, Effect of several factors on the mechanical properties of pressure sensitive adhesives used in transdermal therapeutic systems, Pharm. Sci. Tech. 2 (2000) 16-23.
11. M. Guyot and F. Fawaz, Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol, Int. J. Pharm. 204 (2000) 171-182.
12. T. M. Goulding, Handbook of Adhesive Technology, Marcel Dekker, New York 1994, pp. 549-564.
13. D. G. Maillard-Salin, P. Becourt and G. Couarraze, A study of the adhesive-skin interface: Correlation between adhesion and passage of a drug, Int. J. Pharm. 200 (2000) 121-126.
14. P. Minghetti, F. Cilurzo and L. Montanari, Evaluation of adhesive properties of patches based on acrylic materials, Drug Dev. Ind. Pharm. 25 (1999) 1-6.
15. A. Mehdizadeh, T. Toliyat, M. R. Rouini, S. Abashzadeh and F. Dorkoosh, Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches, Acta Pharm. 54 (2004) 301-317.
16. A. Mehdizadeh, T. Toliyat, M. R. Rouini and F. Kobarfard, Introducing a full validated analytical procedure as an official compendial method for fentanyl transdermal patches, Daru 13 (2005) 47-51.
17. PSTC-1, Peel Adhesion for Single Coated Tapes 180° Angle, Pressure Sensitive Tape Council, Illinois, revised 11/1975.
18. nd ed., Marcel Dekker, New York 1992, pp. 344-369.
19. rd ed., Marcel Dekker, New York 1996, pp. 267-268.
20. C. Puglia, F. Bonina, G. Trapani, M. Franco and M. Ricci, Evaluation of in vitro percutaneous absorption of lorazepam and clonazepam from hydro-alcoholic gel formulations, Int. J. Pharm. 228 (2001) 79-87.
21. Formulation Technology Based on Eudragit® E 100 for Manufacturing of Transdermal Therapy Systems, Data sheet, Rohm GmbH, Darmstadt 2000.
22. P. Chedgzoy, G. Winckle and C. M. Heard, Triclosan: release from transdermal adhesive formulations and in vitro permeation across human epidermal membranes, Int. J. Pharm. 235 (2002) 229-236.